Cargando…

Development of selective inhibitors of phosphatidylinositol 3-kinase C2α

Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development an...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Wen-Ting, Belabed, Hassane, Kücükdisli, Murat, Metag, Juliane, Roske, Yvette, Prokofeva, Polina, Ohashi, Yohei, Horatscheck, André, Cirillo, Davide, Krauss, Michael, Schmied, Christopher, Neuenschwander, Martin, von Kries, Jens Peter, Médard, Guillaume, Kuster, Bernhard, Perisic, Olga, Williams, Roger L., Daumke, Oliver, Payrastre, Bernard, Severin, Sonia, Nazaré, Marc, Haucke, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613998/
https://www.ncbi.nlm.nih.gov/pubmed/36109648
http://dx.doi.org/10.1038/s41589-022-01118-z
_version_ 1783605551138078720
author Lo, Wen-Ting
Belabed, Hassane
Kücükdisli, Murat
Metag, Juliane
Roske, Yvette
Prokofeva, Polina
Ohashi, Yohei
Horatscheck, André
Cirillo, Davide
Krauss, Michael
Schmied, Christopher
Neuenschwander, Martin
von Kries, Jens Peter
Médard, Guillaume
Kuster, Bernhard
Perisic, Olga
Williams, Roger L.
Daumke, Oliver
Payrastre, Bernard
Severin, Sonia
Nazaré, Marc
Haucke, Volker
author_facet Lo, Wen-Ting
Belabed, Hassane
Kücükdisli, Murat
Metag, Juliane
Roske, Yvette
Prokofeva, Polina
Ohashi, Yohei
Horatscheck, André
Cirillo, Davide
Krauss, Michael
Schmied, Christopher
Neuenschwander, Martin
von Kries, Jens Peter
Médard, Guillaume
Kuster, Bernhard
Perisic, Olga
Williams, Roger L.
Daumke, Oliver
Payrastre, Bernard
Severin, Sonia
Nazaré, Marc
Haucke, Volker
author_sort Lo, Wen-Ting
collection PubMed
description Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development and characterization of PhosphatidylInositol Three-kinase Class twO INhibitors (PITCOINs), potent and highly selective small-molecule inhibitors of PI3KC2α catalytic activity. PITCOIN compounds exhibit strong selectivity toward PI3KC2α due to their unique mode of interaction with the ATP-binding site of the enzyme. We demonstrate that acute inhibition of PI3KC2α-mediated synthesis of phosphatidylinositol 3-phosphates by PITCOINs impairs endocytic membrane dynamics and membrane remodeling during platelet-dependent thrombus formation. PITCOINs are potent and selective cell-permeable inhibitors of PI3KC2α function with potential biomedical applications ranging from thrombosis to diabetes and cancer. [Image: see text]
format Online
Article
Text
id pubmed-7613998
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-76139982022-12-30 Development of selective inhibitors of phosphatidylinositol 3-kinase C2α Lo, Wen-Ting Belabed, Hassane Kücükdisli, Murat Metag, Juliane Roske, Yvette Prokofeva, Polina Ohashi, Yohei Horatscheck, André Cirillo, Davide Krauss, Michael Schmied, Christopher Neuenschwander, Martin von Kries, Jens Peter Médard, Guillaume Kuster, Bernhard Perisic, Olga Williams, Roger L. Daumke, Oliver Payrastre, Bernard Severin, Sonia Nazaré, Marc Haucke, Volker Nat Chem Biol Article Phosphatidylinositol 3-kinase type 2α (PI3KC2α) and related class II PI3K isoforms are of increasing biomedical interest because of their crucial roles in endocytic membrane dynamics, cell division and signaling, angiogenesis, and platelet morphology and function. Herein we report the development and characterization of PhosphatidylInositol Three-kinase Class twO INhibitors (PITCOINs), potent and highly selective small-molecule inhibitors of PI3KC2α catalytic activity. PITCOIN compounds exhibit strong selectivity toward PI3KC2α due to their unique mode of interaction with the ATP-binding site of the enzyme. We demonstrate that acute inhibition of PI3KC2α-mediated synthesis of phosphatidylinositol 3-phosphates by PITCOINs impairs endocytic membrane dynamics and membrane remodeling during platelet-dependent thrombus formation. PITCOINs are potent and selective cell-permeable inhibitors of PI3KC2α function with potential biomedical applications ranging from thrombosis to diabetes and cancer. [Image: see text] Nature Publishing Group US 2022-09-15 2023 /pmc/articles/PMC7613998/ /pubmed/36109648 http://dx.doi.org/10.1038/s41589-022-01118-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Lo, Wen-Ting
Belabed, Hassane
Kücükdisli, Murat
Metag, Juliane
Roske, Yvette
Prokofeva, Polina
Ohashi, Yohei
Horatscheck, André
Cirillo, Davide
Krauss, Michael
Schmied, Christopher
Neuenschwander, Martin
von Kries, Jens Peter
Médard, Guillaume
Kuster, Bernhard
Perisic, Olga
Williams, Roger L.
Daumke, Oliver
Payrastre, Bernard
Severin, Sonia
Nazaré, Marc
Haucke, Volker
Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title_full Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title_fullStr Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title_full_unstemmed Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title_short Development of selective inhibitors of phosphatidylinositol 3-kinase C2α
title_sort development of selective inhibitors of phosphatidylinositol 3-kinase c2α
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613998/
https://www.ncbi.nlm.nih.gov/pubmed/36109648
http://dx.doi.org/10.1038/s41589-022-01118-z
work_keys_str_mv AT lowenting developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT belabedhassane developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT kucukdislimurat developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT metagjuliane developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT roskeyvette developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT prokofevapolina developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT ohashiyohei developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT horatscheckandre developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT cirillodavide developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT kraussmichael developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT schmiedchristopher developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT neuenschwandermartin developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT vonkriesjenspeter developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT medardguillaume developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT kusterbernhard developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT perisicolga developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT williamsrogerl developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT daumkeoliver developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT payrastrebernard developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT severinsonia developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT nazaremarc developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a
AT hauckevolker developmentofselectiveinhibitorsofphosphatidylinositol3kinasec2a